Lee K, Park K, Lee S, Lee C
Theranostics. 2025; 15(3):1077-1093.
PMID: 39776810
PMC: 11700858.
DOI: 10.7150/thno.102743.
Butt A, Bach H
Nanomedicine (Lond). 2024; 20(2):183-206.
PMID: 39670826
PMC: 11730800.
DOI: 10.1080/17435889.2024.2439778.
Chen S, Zhuang D, Jia Q, Guo B, Hu G
Biomater Res. 2024; 28:0042.
PMID: 38952717
PMC: 11214848.
DOI: 10.34133/bmr.0042.
Ullah Z, Roy S, Gu J, Ko Soe S, Jin J, Guo B
Biosensors (Basel). 2024; 14(6).
PMID: 38920586
PMC: 11201439.
DOI: 10.3390/bios14060282.
Zhou M, Yin X, Chen B, Hu S, Zhou W
Asian J Pharm Sci. 2024; 19(3):100924.
PMID: 38903130
PMC: 11186966.
DOI: 10.1016/j.ajps.2024.100924.
Understanding the in vivo Fate of Advanced Materials by Imaging.
Li R, Ng T, Garlin M, Weissleder R, Miller M
Adv Funct Mater. 2024; 30(37).
PMID: 38545084
PMC: 10972611.
DOI: 10.1002/adfm.201910369.
Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors.
Calatayud D, Lledos M, Casarsa F, Pascu S
ACS Bio Med Chem Au. 2023; 3(5):389-417.
PMID: 37876497
PMC: 10591303.
DOI: 10.1021/acsbiomedchemau.3c00021.
Smart Biomimetic Nanozymes for Precise Molecular Imaging: Application and Challenges.
Luo Q, Shao N, Zhang A, Chen C, Wang D, Luo L
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259396
PMC: 9965384.
DOI: 10.3390/ph16020249.
A Remarkable Difference in Pharmacokinetics of Fluorinated Versus Iodinated Photosensitizers Derived from Chlorophyll-a and a Direct Correlation between the Tumor Uptake and Anti-Cancer Activity.
Pandurang T, Cacaccio J, Durrani F, Dukh M, Alsaleh A, Sajjad M
Molecules. 2023; 28(9).
PMID: 37175191
PMC: 10180080.
DOI: 10.3390/molecules28093782.
Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics.
Fujita H, Ohta S, Nakamura N, Somiya M, Horie M
Genes (Basel). 2023; 14(2).
PMID: 36833186
PMC: 9957423.
DOI: 10.3390/genes14020259.
A fluorine-18 labeled radiotracer for PET imaging of γ-glutamyltranspeptidase in living subjects.
Gao D, Miao Y, Ye S, Lu C, Lv G, Li K
RSC Adv. 2022; 11(31):18738-18747.
PMID: 35478654
PMC: 9033604.
DOI: 10.1039/d1ra01324f.
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.
Kubeil M, Martinez I, Bachmann M, Kopka K, Tuck K, Stephan H
Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455430
PMC: 9028399.
DOI: 10.3390/ph15040432.
Boron encapsulated in a liposome can be used for combinational neutron capture therapy.
Li J, Sun Q, Lu C, Xiao H, Guo Z, Duan D
Nat Commun. 2022; 13(1):2143.
PMID: 35440126
PMC: 9018847.
DOI: 10.1038/s41467-022-29780-w.
Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications.
Usama S, Marker S, Vargas S, AghaAmiri S, Ghosh S, Ikoma N
Cancers (Basel). 2022; 14(7).
PMID: 35406390
PMC: 8996983.
DOI: 10.3390/cancers14071619.
The Exception That Proves the Rule: How Sodium Chelation Can Alter the Charge-Cell Binding Correlation of Fluorescein-Based Multimodal Imaging Agents.
Maspero M, Dallanoce C, Wangler B, Wangler C, Hubner R
ChemMedChem. 2022; 17(8):e202100739.
PMID: 35137522
PMC: 9303573.
DOI: 10.1002/cmdc.202100739.
The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery.
Qi S, Wang X, Chang K, Shen W, Yu G, Du J
J Nanobiotechnology. 2022; 20(1):24.
PMID: 34991595
PMC: 8740484.
DOI: 10.1186/s12951-021-01232-5.
Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation.
Maspero M, Cheng X, von Kiedrowski V, Dallanoce C, Wangler B, Hubner R
Pharmaceuticals (Basel). 2021; 14(10).
PMID: 34681213
PMC: 8541144.
DOI: 10.3390/ph14100989.
PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study.
Hubner R, Paretzki A, von Kiedrowski V, Maspero M, Cheng X, Davarci G
Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34199635
PMC: 8226452.
DOI: 10.3390/ph14060531.
Bright red aggregation-induced emission nanoparticles for multifunctional applications in cancer therapy.
Zhang L, Che W, Yang Z, Liu X, Liu S, Xie Z
Chem Sci. 2021; 11(9):2369-2374.
PMID: 34084398
PMC: 8157307.
DOI: 10.1039/c9sc06310b.
MoS-based nanocomposites for cancer diagnosis and therapy.
Wang J, Sui L, Huang J, Miao L, Nie Y, Wang K
Bioact Mater. 2021; 6(11):4209-4242.
PMID: 33997503
PMC: 8102209.
DOI: 10.1016/j.bioactmat.2021.04.021.